Phenotype, genotype, and management of congenital fibrosis of extraocular muscles type 1 in 16 Chinese families

Moxin Chen, Rui Huang, Yingjie Zhang, Deyi Jasmine Zhu, Shu Qin, Pengcheng Xun, Jing Zhang, Ping Gu, Lin LiGraefe 2022 · DOI

TL;DR

This study investigates Congenital Fibrosis of Extraocular Muscles type 1 (CFEOM1) in Chinese families, identifying three specific KIF21A gene mutations as "hotspots" for the condition. The research also highlights the significant role of germline mosaicism and introduces a promising new surgical technique for treating ptosis in affected individuals.

What Problem Does This Paper Address?

Congenital Fibrosis of Extraocular Muscles (CFEOM) is a group of rare genetic disorders characterized by impaired eye movement and drooping eyelids (ptosis). CFEOM type 1 (CFEOM1), the most common subtype, is typically inherited in an autosomal dominant pattern and is caused by mutations in the KIF21A gene. While KIF21A mutations are known to cause CFEOM1, understanding the specific mutational landscape in different populations and developing effective management strategies, particularly for ptosis, remains an ongoing challenge. This paper aims to characterize the genetic basis and clinical manifestations of CFEOM1 in Chinese families, identify common mutation patterns, and evaluate a novel surgical approach for ptosis.

Methods

The researchers conducted a comprehensive study involving 35 patients from 16 Chinese CFEOM1 families. Their methodology included:

  • Clinical Examinations: Detailed ocular examinations and Magnetic Resonance Imaging (MRI) were performed to assess the phenotype, including ptosis, eye movement limitations, and muscle abnormalities.
  • Genetic Analysis: Genomic DNA from probands and family members was sequenced to identify causative mutations in the KIF21A gene.
  • Linkage Analysis: Microsatellite markers were used to analyze genetic linkage across the KIF21A locus, helping to confirm inheritance patterns.
  • Surgical Intervention: A novel surgical procedure, the "modified levator muscle complex suspension," was applied to patients with ptosis, and outcomes were evaluated.

Datasets

The study utilized clinical data and genomic DNA samples from 35 patients across 16 Chinese CFEOM1 families. This forms the primary dataset for the genetic and clinical analyses. The authors also integrated their findings with data from previous studies on CFEOM1 patients globally to provide a broader perspective on mutation rates and mosaicism.

Key Insights and Ideas

  • Hotspot Mutations: The study identified three specific KIF21A gene mutations (c.2860C>T (p.R954W), c.2861G>T (p.R954L), and c.2861G>A (p.R954Q)) as "hotspots" in Chinese CFEOM1 families. This suggests that focusing screening efforts on these specific mutations could be more efficient for diagnosis.
  • Germline Mosaicism: A significant finding was the high occurrence of germline mosaicism (where a mutation is present in the parents' germ cells but not their somatic cells, leading to unaffected parents with affected offspring). This was observed in 8 out of 16 families and is crucial for genetic counseling.
  • Novel Surgical Approach: The paper introduces and evaluates a "modified levator muscle complex suspension" for ptosis correction. This technique appears to offer high safety and efficacy, potentially overcoming limitations of traditional ptosis surgeries in CFEOM1 patients.
  • Phenotypic Consistency: Affected individuals consistently presented with bilateral non-progressive ptosis, restricted horizontal eye movement, fixed infraduction, and compensatory chin-up head posture, aligning with the classical CFEOM1 phenotype. MRI revealed muscle abnormalities, often hypoplasia.

Key Results

  • Three heterozygous KIF21A mutations were identified: c.2860C>T (p.R954W) in eight families, c.2861G>T (p.R954L) in two families, and c.2861G>A (p.R954Q) in two families.
  • Germline mosaicism was implicated in 8 out of 16 families, suggesting a substantial rate of this phenomenon in CFEOM1.
  • When combined with previous studies, the identified mutations (p.R954W, p.R954L, p.R954Q) represent the most common mutations in CFEOM1 families globally, with an overall mosaicism rate of 38.1%.
  • Two patients underwent the modified levator muscle complex suspension surgery and achieved excellent results without complications, demonstrating its potential effectiveness.

Limitations and Future Work

The authors acknowledge several limitations:

  • Disease Mechanism: While the study identifies genetic causes and clinical features, it plays a limited role in investigating the detailed molecular mechanisms of the disease. Further functional studies at cellular and animal levels are needed.
  • Unidentified Mutations: A portion of families (25%) did not have identified KIF21A mutations, suggesting other genetic factors might be involved or that mutations lie in regions not analyzed.
  • Mosaicism Confirmation: The mosaicism rate was based on assumptions, as direct confirmation through sperm or ovum samples was not feasible.
  • Limited Surgical Cohort: The number of patients eligible for the novel ptosis surgery was small, necessitating more clinical practice to gather extensive evidence on its effectiveness and safety.

Future work should prioritize screening for the identified hotspot mutations in CFEOM1 patients and further investigate the role of germline mosaicism in genetic counseling. The promising results of the modified levator muscle complex suspension suggest it could become a valuable surgical option for CFEOM1 patients with ptosis.

Summary updated

Abstract

Instead of evaluating the whole CFEOM1 gene variant, hotspot mutations could be given priority for screening. The occurrence of germline mosaicism has to be taken into account in genetic counseling. Patients with CFEOM1 who have ptosis may benefit from an innovative surgical procedure called modified levator muscle complex suspension.
BibTeX
@inproceedings{chen2022phenotype,
  author = {Moxin Chen and Rui Huang and Yingjie Zhang and Deyi Jasmine Zhu and Shu Qin and Pengcheng Xun and Jing Zhang and Ping Gu and Lin Li},
  title = {{Phenotype, genotype, and management of congenital fibrosis of extraocular muscles type 1 in 16 Chinese families}},
  booktitle = {Graefe},
  year = {2022},
  doi = {10.1007/s00417-022-05830-3},
}
Figure